Results 11 to 20 of about 11,811 (202)
Topical Minoxidil and Low-Dose Oral Minoxidil in Onychodystrophy: A Proposed Treatment Algorithm. [PDF]
J Cosmet DermatolABSTRACT Background Onychodystrophy includes diverse nail disorders that may impair function and quality of life. Because nails grow slowly, adjunctive therapies that promote nail growth are of increasing interest. Aim This review examines the evidence for minoxidil in nail growth and nail disorders and proposes a treatment algorithm for its adjunctive
Gupta AK, Talukder M, Lipner SR.
europepmc +2 more sources
Research Progress on Platelet-Rich Plasma (PRP) in the Treatment of Androgenetic Alopecia. [PDF]
J Cosmet DermatolABSTRACT Background Androgenetic alopecia (AGA) is the most common cause of progressive hair loss, significantly affecting quality of life. Current therapies, such as minoxidil, finasteride, and hair transplantation, show variable efficacy and may be associated with adverse effects.
Zhong Z, Luo L, Zhao L, Yue X, Lu Y.
europepmc +2 more sources
Rutin Stabilises β-Catenin Through GSK3β Inhibition to Promote Hair Follicle Regeneration. [PDF]
Cell ProlifRutin directly binds to GSK3β, stabilising β‐catenin and activating Wnt/β‐catenin signalling to drive hair cycle.
Zhang Y +10 more
europepmc +2 more sources
Minoxidil and Dexamethasone Eluting Nanofiber Dressing for Cutaneous Wound Healing in Rat [PDF]
Pharmaceutical Sciences, 2023 Background: Minoxidil is an antihypertensive agent and vasodilator which may help to promote local blood flow thus hastening the closure of excisional skin wounds. Corticosteroids may down-regulate wound healing.
Saber khozan +4 more
doaj +1 more source
Successful management of suspected minoxidil toxicosis in a cat following accidental dermal exposure
Veterinární Medicína, 2022 Minoxidil was originally introduced as a potent vasodilator, but is now widely used as a topical treatment for human alopecia. A 4-year-old neutered male Norwegian Forest cat presented with a 2-day history of anorexia, lethargy, and dyspnoea.
Song JH, Kim SY, Moon JH, Jung DI
doaj +1 more source
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2023 The treatment and prevention of hair loss have been a serious aesthetic problem for the population for a long time due to the widespread occurrence of the condition and its undesirable medical and social consequences.
V. V. Hladyshev +6 more
doaj +1 more source
Androgenetic alopecia: a review [PDF]
, 2017 Purpose Androgenetic alopecia, commonly known as male pattern baldness, is the most common type of progressive hair loss disorder in men. The aim of this paper is to review recent advances in understanding the pathophysiology and molecular mechanism
Caro, Gemma +7 more
core +1 more source
Multi-therapies in androgenetic alopecia: review and clinical experiences. [PDF]
, 2016 Androgenetic alopecia (AGA) is a genetically determined progressive hair-loss condition which represents the most common cause of hair loss in men. The use of the medical term androgenetic alopecia reflects current knowledge about the important role of
Anzalone, Alessia +6 more
core +1 more source
Pharmaceutics, 2018 In this work, we examined enhanced skin delivery of minoxidil applied in nanoemulsions incorporating skin penetration enhancers. Aliquots of fully characterized oil-in-water nanoemulsions (1 mL), containing minoxidil (2%) and the skin penetration ...
Eman Abd +3 more
doaj +1 more source
Trichoscopic Evaluation of the Effectiveness of Topical Stemoxydine for Hair Restoration in Androgenetic Alopecia: A Prospective Pre-Post Single-Arm Exploratory Study. [PDF]
J Cosmet DermatolABSTRACT Background Androgenetic Alopecia (AGA) is a prevalent hereditary disorder leading to hair loss. Stemoxydine, a competitive (Prolyl 4‐hydroxylase) inhibitor, may activate Hypoxia‐Inducible Factor 1‐alpha signaling and shorten the hair kenogen phase, potentially increasing hair density as a proposed treatment for AGA.
Elattar YA +3 more
europepmc +2 more sources